The issues surrounding access to drugs and devices is often invisible to Medicare beneficiaries, but a new report by the U.S. Centers for Medicare & Medicaid Services expects Medicare spending to jump 7.1 percent in the current year. That increase seems certain to apply price pressure across the health care spectrum, including on makers of drugs, medical devices and diagnostics, at a time when price is a particularly salient consideration in health care.